News
Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from customers using ancestry testing and other services.
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.
PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking ...
The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...
Regneron stock crashed today following disappointing COPD trials data. Here's what makes REGN shares worth buying on the ...
The bipartisan lawsuit was filed on Monday in St. Louis alongside a separate objection to the bankruptcy sale and is being ...
960 The Ref on MSN2d
27 states sue 23andMe to prevent sale of private informationPeople did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...
Regeneron is willing to make a new bid for 23andMe's assets, but wants a $10 million breakup fee if Wojcicki’s bid is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback